WO2024062457 - TREATING SKIN IRRITATION FROM APPLICATION OF AN ALTERNATING ELECTRIC FIELD

National phase entry:
Publication Number WO/2024/062457
Publication Date 28.03.2024
International Application No. PCT/IB2023/059418
International Filing Date 22.09.2023
Title **
[English] TREATING SKIN IRRITATION FROM APPLICATION OF AN ALTERNATING ELECTRIC FIELD
[French] TRAITEMENT DE L'IRRITATION DE LA PEAU À PARTIR DE L'APPLICATION D'UN CHAMP ÉLECTRIQUE ALTERNATIF
Applicants **
NOVOCURE GMBH
Inventors
AVIGDOR, Lilach
VOLOSHIN-SELA, Tali
WEINBERG, Uri
Priority Data
63/409,581   23.09.2022   US
18/371,625   22.09.2023   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2323
EPO Filing, Examination, Granting10669
Japan Filing, Examination, Granting2294
South Korea Filing, Examination, Granting2341
USA Filing, Examination, Granting9540
MasterCard Visa
Total: 27,167

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] An interleukin 23 (IL-23) inhibitor for use in a method of reducing skin irritation in a subject caused by application of an alternating electric field, the method includes: delivering an interleukin 23 (IL-23) inhibitor to the subject; and applying an alternating electric field to the subject at a frequency between approximately 50 kHz and approximately 10,000 kHz[French] L'invention concerne un inhibiteur de l'interleukine 23 (IL-23) destiné à être utilisé dans une méthode permettant de réduire l'irritation de la peau chez un sujet provoqué par l'application d'un champ électrique alternatif, la méthode comprenant : l'administration d'un inhibiteur de l'interleukine 23 (IL-23) au sujet ; et l'application d'un champ électrique alternatif au sujet à une fréquence comprise entre environ 50 kHz et environ 10000 kHz

Rejoining the server...